Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form
Reexamination Certificate
2011-03-15
2011-03-15
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
C424S093200
Reexamination Certificate
active
07906125
ABSTRACT:
An injectable or insertable dosage form comprising a biodisintegrable binder and an ablation agent in a concentration effective to cause tissue necrosis. The injectable dosage form is a solid or semi-solid dosage form. Due to the solid or semi-solid nature of the dosage form, retention at the site of injection or insertion is improved, thereby improving delivery efficiency of the ablation agents within the dosage form and/or reducing the nonspecific tissue damage associated with the dosage form.
REFERENCES:
patent: 4927806 (1990-05-01), Kramer et al.
patent: 5147631 (1992-09-01), Glajch et al.
patent: 5469854 (1995-11-01), Unger et al.
patent: 5733572 (1998-03-01), Unger et al.
patent: 5770222 (1998-06-01), Unger et al.
patent: 6123923 (2000-09-01), Unger et al.
patent: 6168777 (2001-01-01), Greff et al.
patent: 6228398 (2001-05-01), Devane et al.
patent: 6231591 (2001-05-01), Desai
patent: 6277391 (2001-08-01), Seo et al.
patent: 6443898 (2002-09-01), Unger et al.
patent: 6461296 (2002-10-01), Desai
patent: 6495164 (2002-12-01), Ramstack et al.
patent: 6869927 (2005-03-01), Gentz et al.
patent: 6905475 (2005-06-01), Hauschild et al.
patent: 7015253 (2006-03-01), Escandon et al.
patent: 2002/0010150 (2002-01-01), Cortese et al.
patent: 2002/0082610 (2002-06-01), Cioanta et al.
patent: 2003/0064998 (2003-04-01), Francois et al.
patent: 2003/0130575 (2003-07-01), Desai
patent: 2005/0064046 (2005-03-01), DiTrolio
patent: 1 078 636 (2001-02-01), None
patent: 1 197 208 (2002-04-01), None
patent: 811717 (1959-04-01), None
patent: WO 03/005889 (2003-01-01), None
Rehman, J.; Tissue Chemoablation,(2003),Journal of Endourology, vol. 17, No. 8: p. 1.
Joseph V. Ditrolio, “A Novel Treatment for BPH: Transurethral Ethanol Ablation of the Prostate (TEAP),” slide presentation, 20thWorld Congress on Endourology & Shockwave, Sep. 20, 2002, Genoa, Italy, 3 pp.
Bucay-Couto Weenna
Gellman Barry N.
Ma Enxin
Madenjian Arthur
Zhong Sheng-Ping
Betton Timothy E
Bonham David B.
Boston Scientific Scimed Inc.
Mayer & William PC
Padmanabhan Sreeni
LandOfFree
Solid or semi-solid therapeutic formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid or semi-solid therapeutic formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid or semi-solid therapeutic formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2780551